Recombinant Heparosan Factor VIIa Conjugate (Caisson Biotech)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameRecombinant Heparosan Factor VIIa Conjugate (Caisson Biotech)
Drug Alias NameNNC-947
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionCoagulation factor VII stimulants
TargetsCoagulation factor VII
Therapy Area/IndicationsHemophilia A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesDenmark
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCaisson Biotech LLC
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCaisson Biotech LLCNovo Nordisk A/S
Active IndicationsN/A
Inactive IndicationsHemophilia A

Other Information

ATC CodeN/A
Related LinksN/A